Trial Profile
Phase 2 Study of Orally Formulated Heat-killed Mycobacterium Vaccae Study in TB Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2013
Price :
$35
*
At a glance
- Drugs Mycobacterium vaccae vaccine (Primary)
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 02 Aug 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.